Publicaciones en colaboración con investigadores/as de Medical University of Vienna (17)

2024

  1. European pollen reanalysis, 1980-2022, for alder, birch, and olive

    Scientific data, Vol. 11, Núm. 1, pp. 1082

  2. Needs assessment for creation of a platform trial network in metabolic-dysfunction associated steatohepatitis

    Communications Medicine, Vol. 4, Núm. 1

2023

  1. Alginate sulfate-nanoparticles loaded with hepatocyte growth factor and insulin-like growth factor-1 improve left ventricular repair in a porcine model of myocardial ischemia reperfusion injury

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 184, pp. 83-91

2022

  1. TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammation

    Journal of Hepatology, Vol. 77, Núm. 4, pp. 991-1004

2021

  1. Sin título en SCOPUS

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 118, Núm. 12

  2. TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms

    Gut, Vol. 70, Núm. 7, pp. 1345-1361

2020

  1. Single-Cell RNA Sequencing Analysis Reveals a Crucial Role for CTHRC1 (Collagen Triple Helix Repeat Containing 1) Cardiac Fibroblasts After Myocardial Infarction

    Circulation, Vol. 142, Núm. 19, pp. 1831-1847

2019

  1. Fine-Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver Disease

    Hepatology, Vol. 69, Núm. 2, pp. 699-716

  2. Non-parenchymal TREM-2 protects the liver from immune-mediated hepatocellular damage

    Gut, Vol. 68, Núm. 3, pp. 533-546

  3. The challenges of primary biliary cholangitis: What is new and what needs to be done

    Journal of Autoimmunity, Vol. 105

2018

  1. Differential effects of FXR or TGR5 activation in cholangiocarcinoma progression

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1864, Núm. 4, pp. 1335-1344

2017

  1. Global position paper on cardiovascular regenerative medicine

    European Heart Journal

2016

  1. Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)

    Nature Reviews Gastroenterology and Hepatology, Vol. 13, Núm. 5, pp. 261-280

2014

  1. Coinhibitory suppression of t cell activation by CD40 protects against obesity and adipose tissue inflammation in mice

    Circulation, Vol. 129, Núm. 23, pp. 2414-2425

2013

  1. The significance of genetics for cholangiocarcinoma development

    Annals of Translational Medicine, Vol. 1, Núm. 3

2011

  1. EVI1-mediated down regulation of MIR449A is essential for the survival of EVI1 positive leukaemic cells

    British Journal of Haematology, Vol. 154, Núm. 3, pp. 337-348

  2. Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q

    Leukemia, Vol. 25, Núm. 1, pp. 110-120